COVID-19-associated ARDS treated with DEXamethasone (CoDEX): study design and rationale for a randomized trial

OBJECTIVE: The infection caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spreads worldwide and is considered a pandemic. The most common manifestation of SARS-CoV-2 infection (coronavirus disease 2019 - COVID-19) is viral pneumonia with varying degrees of respiratory compr...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomazini, Bruno Martins, Maia, Israel Silva, Bueno, Flavia Regina, Silva, Maria Vitoria Aparecida Oliveira, Baldassare, Franca Pellison, Costa, Eduardo Leite Vieira, Moura, Ricardo Antonio Bonifácio, Honorato, Michele Ouriques, Costa, André Nathan, Cavalcanti, Alexandre Biasi, Rosa, Regis Goulart, Avezum, Álvaro, Veiga, Viviane Cordeiro, Lopes, Renato Delascio, Damiani, Lucas Petri, Machado, Flávia Ribeiro, Berwanger, Otavio, de Azevedo, Luciano César Pontes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação de Medicina Intensiva Brasileira - AMIB 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595716/
https://www.ncbi.nlm.nih.gov/pubmed/33053024
http://dx.doi.org/10.5935/0103-507X.20200063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595716/
https://www.ncbi.nlm.nih.gov/pubmed/33053024
http://dx.doi.org/10.5935/0103-507X.20200063

Ejemplares similares